Riskpilot← Back to searchSign inGet full accessHaemochrom Diagnostica AB
ABIn liquidationOrg 5565616728Research and experimental development on natural sciences and engineering · NACE 7210Est. 19981 employees
Revenue 2024
SEK 0
EBITDA margin
—
-102% vs 2023
Equity ratio
51.4%
Financial strength
Net profit 2024
SEK -10K
-103% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -10K | -102% |
| Net profit | SEK -10K | -103% |
| Total assets | SEK 226K | -74% |
| Equity | SEK 116K | -78% |
| Employees | 1 | — |
Legal name
Haemochrom Diagnostica AB
Org number
5565616728
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
28 oktober 1998
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget skall bedriva distribution och försäljning inom främst läkemedelsbranschen vari innefattas även diagnostika, ävensom idka därmed förenlig verksamhet.
Address
Phone
+46317062000
Email
lili-ann.t.tullborg@lawtax.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 12 926 | 6 224 | 2 650 | 502 | 0 |
| Staff expenses | — | — | — | — | −0 |
| EBITDA | 5 165 | 2 381 | 1 490 | 455 | −10 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | 5 165 | 2 381 | 1 490 | 455 | −10 |
| Net financials | −341 | −118 | −94 | 26 | −1 |
| Profit before tax | 4 823 | 2 264 | 1 396 | 481 | −10 |
| Tax | −1 033 | −469 | −290 | −99 | — |
| Net profit | 3 790 | 1 795 | 1 106 | 382 | −10 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 18 731 | 19 012 | 19 936 | 853 | 226 |
| Equity | 16 244 | 18 039 | 19 145 | 526 | 116 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 2 487 | 973 | 792 | 327 | 110 |
| Total debt | 2 487 | 973 | 792 | 327 | 110 |
EBITDA margin
-988600.0%
This company
15.8%
Market median
-6257062% vs market
20202024
Equity ratio
51.4%
This company
38.2%
Market median
+35% vs market
20202024
Return on equity
-9.0%
This company
18.4%
Market median
-149% vs market
20202024
Net profit margin
-1045100.0%
This company
8.1%
Market median
-12902569% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.95×
This company
0.62×
Market median
+53% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LT Liquidator | Liquidator | 2025 |
| Former (3) | ||
AC Chief Auditor | Chief Auditor | 2022 – 2023 |
LF Authorized Recipient of Service | Authorized Recipient of Service | 2022 – 2025 |
SK Chief Auditor | Chief Auditor | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Deputy Board Member | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HAEMOCHROM DIAGNOSTICA GMBH
Haemochrom Diagnostica AB (this company)Board members of Haemochrom Diagnostica AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lili-Ann Tapper Tullborg | Liquidator | 0 companies |
| Anna Carina Christiansson | Chief Auditor | 0 companies |
| Lise Frank Mendel | Authorized Recipient of Service | 0 companies |
| Sigge Karl Simon Kléen | Chief Auditor | 0 companies |
| Andreas Karst | Deputy Board Member | 0 companies |
| Hans-Peter Brockmann | Board of Directors | 0 companies |